Saba Capital Management, L.P. Buys 1,633 Shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) Stock

BlackRock Health Sciences Term Trust (NYSE:BMEZ) major shareholder Saba Capital Management, L.P. purchased 1,633 shares of BlackRock Health Sciences Term Trust stock in a transaction that occurred on Friday, September 27th. The stock was acquired at an average price of 15.89 per share, for a total transaction of 25,948.37. Following the transaction, the insider now directly owns 20,653,378 shares of the company’s stock, valued at approximately 328,182,176.42. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Major shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Saba Capital Management, L.P. also recently made the following trade(s):

• On Monday, September 30th, Saba Capital Management, L.P. purchased 8,012 shares of BlackRock Health Sciences Term Trust stock. The stock was acquired at an average price of 15.84 per share, for a total transaction of 126,910.08.
• On Wednesday, September 25th, Saba Capital Management, L.P. purchased 300 shares of BlackRock Health Sciences Term Trust stock. The stock was acquired at an average price of 15.73 per share, for a total transaction of 4,719.00.
• On Monday, September 23rd, Saba Capital Management, L.P. purchased 2,006 shares of BlackRock Health Sciences Term Trust stock. The stock was acquired at an average price of 15.98 per share, for a total transaction of 32,055.88.
• On Thursday, September 19th, Saba Capital Management, L.P. purchased 15,455 shares of BlackRock Health Sciences Term Trust stock. The stock was acquired at an average price of 16.14 per share, for a total transaction of 249,443.70.
• On Tuesday, September 17th, Saba Capital Management, L.P. acquired 27,148 shares of BlackRock Health Sciences Term Trust stock. The shares were purchased at an average price of 15.93 per share, for a total transaction of 432,467.64.

BlackRock Health Sciences Term Trust Trading Up 0.3 %

BMEZ stock opened at 15.89 on Wednesday. BlackRock Health Sciences Term Trust has a twelve month low of 12.93 and a twelve month high of 16.59. The firm’s fifty day simple moving average is 15.85 and its two-hundred day simple moving average is 15.52.

BlackRock Health Sciences Term Trust Announces Dividend

The company also recently disclosed a monthly dividend, which will be paid on Thursday, October 31st. Shareholders of record on Tuesday, October 15th will be given a dividend of $0.176 per share. This represents a $2.11 dividend on an annualized basis and a yield of 13.29%. The ex-dividend date of this dividend is Tuesday, October 15th.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of BMEZ. Benjamin F. Edwards & Company Inc. increased its position in BlackRock Health Sciences Term Trust by 21.7% during the first quarter. Benjamin F. Edwards & Company Inc. now owns 5,830 shares of the company’s stock valued at $96,000 after acquiring an additional 1,038 shares during the last quarter. Register Financial Advisors LLC increased its position in BlackRock Health Sciences Term Trust by 5,365.6% during the second quarter. Register Financial Advisors LLC now owns 6,832 shares of the company’s stock valued at $105,000 after acquiring an additional 6,707 shares during the last quarter. Shaker Financial Services LLC bought a new position in BlackRock Health Sciences Term Trust during the second quarter valued at $184,000. Comerica Bank boosted its stake in shares of BlackRock Health Sciences Term Trust by 31.1% during the first quarter. Comerica Bank now owns 15,469 shares of the company’s stock valued at $254,000 after purchasing an additional 3,671 shares during the period. Finally, Dakota Wealth Management boosted its stake in shares of BlackRock Health Sciences Term Trust by 5.3% during the second quarter. Dakota Wealth Management now owns 18,242 shares of the company’s stock valued at $280,000 after purchasing an additional 915 shares during the period.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.